Document is current
Any future updates will be listed below
-
Authors
Egerton, A.
Broberg, B. V.
Van Haren, N.
Merritt, K.
Barker, G. J. https://orcid.org/0000-0002-5214-7421
Lythgoe, D. J.
Perez-Iglesias, R.
Baandrup, L.
Düring, S. W.
Sendt, K. V.
Stone, J. M.
Rostrup, E.
Sommer, I. E.
Glenthøj, B.
Kahn, R. S.
Dazzan, P.
McGuire, P.
- License Information
-
More Information
Article History
Received: 22 September 2017
Revised: 15 March 2018
Accepted: 4 April 2018
First Online: 7 June 2018
Compliance with ethical standards
:
: G.J.B. received honoraria for teaching from General Electric Healthcare during the course of this study, and acts as a consultant for IXICO. A.E. has received research funding from the Roche and consultancy payment from Heptares Therapeutics. B.G. is the leader of a Lundbeck Foundation Center of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), which is partially financed by an independent grant from the Lundbeck Foundation based on international review and partially financed by the Mental Health Services in the Capital Region of Denmark, the University of Copenhagen and other foundations. P.M. has received consultancy payment for Sunovion and Takeda. R.P.I. has received honoraria as a speaker for Lundbeck. J.M.S. has received honoraria from Roche and Janssen and consultancy payment from Takeda. The remaining authors declare that they have no conflict of interest.
